Results
Sun Pharma Q2 FY27 Net Profit at ₹19.9 Billion
Sun Pharma reported Q2 FY27 sales of ₹161,000 million, an 11.8% YoY growth, with an EBITDA of ₹47,439 million.
The US business declined 8.2% YoY due to lenalidomide erosion, while the India formulatio
